Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.
Ito T, Okusaka T, Nishida T, Yamao K, Igarashi H, Morizane C, Kondo S, Mizuno N, Hara K, Sawaki A, Hashigaki S, Kimura N, Murakami M, Ohki E, Chao RC, Imamura M. Ito T, et al. Among authors: sawaki a. Invest New Drugs. 2013 Oct;31(5):1265-74. doi: 10.1007/s10637-012-9910-y. Epub 2012 Dec 27. Invest New Drugs. 2013. PMID: 23269537 Free PMC article. Clinical Trial.
Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.
Ito T, Okusaka T, Nishida T, Yamao K, Igarashi H, Morizane C, Kondo S, Mizuno N, Hara K, Sawaki A, Hashigaki S, Kimura N, Murakami M, Ohki E, Chao RC, Imamura M. Ito T, et al. Among authors: sawaki a. Invest New Drugs. 2019 Jun;37(3):591. doi: 10.1007/s10637-019-00757-9. Invest New Drugs. 2019. PMID: 30903344 Free PMC article.
Clinical impact of radiotherapy for locally advanced pancreatic cancer.
Sawaki A, Hoki N, Ito S, Matsumoto K, Mizuno N, Hara K, Takagi T, Kobayashi Y, Sawai Y, Kawai H, Tajika M, Nakamura T, Yamao K. Sawaki A, et al. J Gastroenterol. 2009;44(12):1209-14. doi: 10.1007/s00535-009-0116-9. J Gastroenterol. 2009. PMID: 19705054
Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial.
Komatsu Y, Doi T, Sawaki A, Kanda T, Yamada Y, Kuss I, Demetri GD, Nishida T. Komatsu Y, et al. Among authors: sawaki a. Int J Clin Oncol. 2015 Oct;20(5):905-12. doi: 10.1007/s10147-015-0790-y. Epub 2015 Feb 6. Int J Clin Oncol. 2015. PMID: 25655899 Free PMC article. Clinical Trial.
142 results